Ursodeoxycholic acid and Simponi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ursodeoxycholic acid (ursodiol) and Simponi (golimumab). Common drug interactions include lower gastrointestinal haemorrhage among females and enteritis infectious among males.
The phase IV clinical study analyzes what interactions people have when they take Ursodeoxycholic acid and Simponi. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Ursodeoxycholic acid?
Ursodeoxycholic acid has active ingredients of ursodiol. It is often used in biliary cirrhosis primary. eHealthMe is studying from 7,528 Ursodeoxycholic acid users. Check the latest studies of Ursodeoxycholic acid.
What is Simponi?
Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.
14 people who take Ursodeoxycholic acid and Simponi together, and have interactions are studied.

What are the common drug interactions of Ursodeoxycholic Acid and Simponi, by gender? *:
female:
- Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
- Toxic skin eruption (skin breakdown due to toxic substance)
- Candida sepsis (candida in blood stream)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Breast cancer
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Arthralgia (joint pain)
- Foot deformity (functional disability of foot)
- Urinary tract infection
- Abdominal pain
male:
- Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
- Anaemia (lack of blood)
- Drug ineffective
- Psoriasis (immune-mediated disease that affects the skin)
- Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
What are the common drug interactions of Ursodeoxycholic Acid and Simponi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Drug ineffective
- Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
30-39:
- Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
40-49:
- Abdominal pain
- Breast cancer
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Pyrexia (fever)
- Colitis ulcerative (inflammation of colon with ulcer)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Leukopenia (less number of white blood cells in blood)
- Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
- Toxic skin eruption (skin breakdown due to toxic substance)
- Candida sepsis (candida in blood stream)
50-59:
n/a
60+:
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 78.57%
- Enteritis Infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus): 3 people, 21.43%
- Anaemia (lack of blood): 3 people, 21.43%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.14%
- Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
- Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.14%
- Cholangitis Sclerosing (infection and obstruction of bile duct): 1 person, 7.14%
- Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Ursodeoxycholic acid and Simponi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ursodeoxycholic acid (7,528 reports)
- Simponi (86,328 reports)
Browse all drug interactions of Ursodeoxycholic acid and Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ursodeoxycholic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ursodeoxycholic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simponi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on ursodiol and golimumab (the active ingredients of Ursodeoxycholic acid and Simponi, respectively), and Ursodeoxycholic acid and Simponi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nulytely cause Nosebleed? - 6 seconds ago
- Could Aleve cause Nocturia Aggravated? - 21 seconds ago
- Could Zantac cause Corneal Oedema? - 23 seconds ago
- Could Wellbutrin cause Derealisation? - 23 seconds ago
- Drug interactions of Fluvastatin Sodium and Indomethacin - 33 seconds ago
- Could Aspirin cause Myopericarditis? - 35 seconds ago
- Could Nifedipine cause Lymphocyte Count Decreased? - a minute ago
- Could Atorvastatin Calcium cause Prurigo? - a minute ago
- Drug interactions of Acetaminophen and Nexviazyme - a minute ago
- Drug interactions of Scopolamine and Bentyl - a minute ago